Tell Your Story
What You Grow
Rachel puts pen to paper to cope with cancer. Here’s her poem, What You Grow.
Liz Hiles
June 12, 2022
Menu
Rachel puts pen to paper to cope with cancer. Here’s her poem, What You Grow.
Gryt Health team Member, Christian Bullock, shares a very specific lymphoma experience he had. Read his story and let us know about your medical triggers or the medical equipment you’ve dealt with.
As of January 2021, the Food and Drug Administration (FDA) has announced the approval of a new medication for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, who are not eligible for autologous stem cell transplant. The new drug, called Monjuvi (tafasitimab) is a targeted therapy that will be used in combination with lenalidomide (Revlimid). Other combinations are currently under investigation.
Jessica shares about the hit her dignity took when she received a second cancer diagnosis and learned she would lose a breast at age 25.
B-cell lymphoma survivor, David, shares what he found GRYT to be.
